Press Releases from DelveInsight Business Research LLP (4878 total)
Acute Myeloid Leukemia Market Size in 7MM is expected to grow at a decent CAGR b …
DelveInsight's "Acute Myeloid Leukemia Treatment Market Insight, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Acute Myeloid Leukemia, historical and forecasted…
Ovarian Cancer Drugs Market Size in 7MM is expected to grow at a decent CAGR by …
DelveInsight's "Ovarian Cancer Market Insight, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of high- and low-grade serous ovarian cancer, its historical and forecasted…
Traumatic Brain Injury Treatment Market Size in 7MM is expected to grow at a dec …
DelveInsight's "Traumatic Brain Injury Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the TBI, historical and forecasted epidemiology and…
Sepsis Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimate …
DelveInsight's "Sepsis Drugs Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Sepsis, historical and forecasted epidemiology as well as…
Alport syndrome Pipeline 2025: Groundbreaking Clinical Advancements by 4+ Global …
With Alport syndrome reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Arteriovenous (AV) Fistula Pipeline 2025: Groundbreaking Clinical Advancements b …
With Arteriovenous (AV) Fistula reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Ischemia Reperfusion Injury Pipeline 2025: Groundbreaking Clinical Advancements …
With Ischemia Reperfusion Injury reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Juvenile Macular Degeneration Pipeline 2025: Groundbreaking Clinical Advancement …
With Juvenile Macular Degeneration reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Urea cycle disorders Pipeline 2025: Groundbreaking Clinical Advancements by 8+ G …
With Urea cycle disorders reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Spinal cord injury Pipeline 2025: Groundbreaking Clinical Advancements by 25+ Gl …
With Spinal cord injury reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a…
Fabry Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Amicus …
Fabry Disease emerging therapies, such as Venglustat, Isaralgagene civaparvovec (ST-920), AMT-191, and others, are expected to boost the Fabry Disease Market in the upcoming years.
DelveInsight…
Acute Coronary Syndrome Market: Epidemiology, Therapies, Companies, DelveInsight …
Acute Coronary Syndrome therapies, such as LODOCO (colchicine), TNKase (tenecteplase), REPATHA (evolocumab), ZONTIVITY (vorapaxar), PRALUENT (alirocumab), LOVENOX (enoxaparin sodium), Aggrastat (tirofiban), REOPRO (abciximab), and others,…
Metachromatic Leukodystrophy Pipeline 2025: Groundbreaking Clinical Advancements …
With Metachromatic Leukodystrophy reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
GM1 Gangliosidosis Market: Epidemiology, Therapies, Companies, DelveInsight | Pa …
GM1 Gangliosidosis therapies, such as PBGM01, and others, are expected to boost the GM1 Gangliosidosis Market in the upcoming years.
DelveInsight has launched a new report…
Tay-Sachs Disease Pipeline 2025: Groundbreaking Clinical Advancements by 4+ Glob …
With Tay-Sachs Disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Multiple Myeloma Pipeline 2025: Groundbreaking Clinical Advancements by 75+ Glob …
With Multiple Myeloma reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Genital Herpes Pipeline 2025: Groundbreaking Clinical Advancements by 18+ Global …
With Genital Herpes reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Eczema Pipeline 2025: Groundbreaking Clinical Advancements by 100+ Global Leader …
With Eczema reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand…
Porphyria Pipeline 2025: Groundbreaking Clinical Advancements by 10+ Global Lead …
With Porphyria reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing demand…
Non-Invasive Prenatal Testing Market Set for Steady Expansion by 2032, Driven by …
Global non-invasive prenatal testing (NIPT) market was valued at USD 3,916 million in 2023 and is projected to grow at a compound annual growth rate…
Vascular Closure Devices Market Set for Steady Expansion by 2032, Driven by Inno …
The vascular closure devices market was valued at USD 1.05 billion in 2023 and is projected to grow at a CAGR of 6.15%, reaching approximately…
Injectable Drug Delivery Devices Market Set for Steady Expansion by 2032, Driven …
The injectable drug delivery devices market was valued at USD 19.63 billion in 2023 and is projected to grow at a compound annual growth rate…
Orthopedic Prosthesis Devices Market Set for Steady Expansion by 2032, Driven by …
The orthopedic prosthesis devices market was valued at USD 2.11 billion in 2023 and is projected to reach approximately USD 2.96 billion by 2030, expanding…
Buerger's disease Pipeline 2025: Groundbreaking Clinical Advancements by 3+ Glob …
With Buerger's disease reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Smoking cessation and nicotine addiction Market: Epidemiology, Therapies, Compan …
Smoking cessation and nicotine addiction emerging therapies, such as Cytisinicline (cytisine), NFL-101, EMB-001, and others, are expected to boost the Smoking cessation and nicotine addiction…
Beta thalassemia Market: Epidemiology, Therapies, Companies, DelveInsight | Nova …
Beta thalassemia emerging therapies, such as Mitapivat (AG-348), and others, are expected to boost the Beta thalassemia Market in the upcoming years.
DelveInsight has launched a…
Warm autoimmune hemolytic anemia Market: Epidemiology, Therapies, Companies, Del …
Warm autoimmune hemolytic anemia emerging therapies, such as Obexelimab (ZB012), Nipocalimab (M281), and others, are expected to boost the Warm autoimmune hemolytic anemia Market in…
Sickle cell disease Market: Epidemiology, Therapies, Companies, DelveInsight | G …
Sickle cell disease therapies, such as CASGEVY (exagamglogene autotemcel), ENDARI (L-glutamine), Mitapivat, Inclacumab, and others, are expected to boost the Sickle cell disease Market in…
Von willebrand disease Market: Epidemiology, Therapies, Companies, DelveInsight …
Von willebrand disease emerging therapies, such as WILATE, VONVENDI, VGA039, Efanesoctocog alfa (BIVV001), and others, are expected to boost the Von willebrand disease Market in…
Cardiac amyloidosis Pipeline 2025: Groundbreaking Clinical Advancements by 20+ G …
With Cardiac amyloidosis reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Primary myelofibrosis Pipeline 2025: Groundbreaking Clinical Advancements by 55+ …
With Primary myelofibrosis reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Fanconi anemia Pipeline 2025: Groundbreaking Clinical Advancements by 3+ Global …
With Fanconi anemia reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Axillary hyperhidrosis Pipeline 2025: Groundbreaking Clinical Advancements by 3+ …
With Axillary hyperhidrosis reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Arteriovenous fistula Pipeline 2025: Groundbreaking Clinical Advancements by 3+ …
With Arteriovenous fistula reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Relapsed or Refractory Myelodysplastic Syndrome Pipeline 2025: Groundbreaking Cl …
With Relapsed or Refractory Myelodysplastic Syndrome reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there…
Relapsing refractory multiple myeloma Pipeline 2025: Groundbreaking Clinical Adv …
With Relapsing refractory multiple myeloma reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is…
Familial Chylomicronemia Syndrome Drugs Market Size in 7MM is expected to grow a …
DelveInsight's "Familial Chylomicronemia Syndrome Market Insights, Epidemiology and Market Forecast- 2034" report delivers an in-depth understanding of the Familial Chylomicronemia Syndrome, historical and forecasted epidemiology…
Congestive Heart Failure Drugs Market Size in 7MM is expected to grow at a decen …
DelveInsight's "Congestive Heart Failure Market Insights, Epidemiology, and Market Forecast- 2034" report delivers an in-depth understanding of the Congestive Heart Failure, historical and forecasted epidemiology…
Non-ST Segment Elevation Acute Coronary Syndromes Drugs Market Size in 7MM is ex …
DelveInsight's "Non-ST Segment Elevation Acute Coronary Syndromes Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth understanding of the Non-ST Segment Elevation Acute…
Polycythemia Vera Drugs Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Polycythemia Vera Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Polycythemia Vera, historical and forecasted epidemiology as well as…
Von Willebrand Disease Drugs Market Size in 7MM is expected to grow at a decent …
DelveInsight's "Von Willebrand Disease Market Insights, Epidemiology, and Market Forecast- 2034" report delivers an in-depth understanding of the Von Willebrand Disease, historical and forecasted epidemiology…
Eosinophilia Drugs Market Size in 7MM is expected to grow at a decent CAGR by 20 …
DelveInsight's "Eosinophilia Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth understanding of the Eosinophilia, historical and forecasted epidemiology as well as the…
Factor Xa Inhibitor Drugs Market Size in 7MM is expected to grow at a decent CAG …
DelveInsight's "Factor Xa Inhibitor Market Insights, Epidemiology, and Market Forecast- 2034" report delivers an in-depth understanding of the Factor Xa Inhibitor, historical and forecasted epidemiology…
Syncope Drugs Market Size in 7MM is expected to grow at a decent CAGR by 2032, e …
DelveInsight's "Syncope Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth understanding of the Syncope, historical and forecasted epidemiology as well as the…
Hematuria Drugs Market Size in 7MM is expected to grow at a decent CAGR by 2032, …
DelveInsight's "Hematuria Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth understanding of the Hematuria, historical and forecasted epidemiology as well as the…
Embolotherapy Treatment Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Embolotherapy Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth understanding of the Embolotherapy, historical and forecasted epidemiology as well as the…
Androgenetic alopecia Pipeline 2025: Groundbreaking Clinical Advancements by 12+ …
With Androgenetic alopecia reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Obsessive-compulsive disorder Pipeline 2025: Groundbreaking Clinical Advancement …
With Obsessive-compulsive disorder reaching epidemic proportions globally and contributing significantly to comorbid conditions such as diabetes, cardiovascular disease, and certain cancers, there is a growing…
Lyme Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Pfizer, …
Lyme Disease therapies are expected to boost the Lyme Disease Market in the upcoming years.
DelveInsight has launched a new report on "Lyme Disease - Market…
Whiplash injury Market: Epidemiology, Therapies, Companies, DelveInsight | Advan …
Whiplash injury emerging therapies are expected to boost the Whiplash injury Market in the upcoming years.
DelveInsight has launched a new report on "Whiplash injury -…
